๐
$NKGEN BIOTECH (NKGN.US)$ Shares Rise 46.4% Premarket After Clearance to Start Mid-Stage Study on Alzheimer's Disease Cell Therapy
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Operations Specialist, Shellback Sailor, Human Calculator, Long-time Investor, Stock Market Secrets, Technical Analyst.
273Followers
13Following
1427Visitors
Follow